PMDA drug package insert
ホスホマイシンナトリウム静注用0.5g「日医工」
PMDA Prescription drug · 日医工株式会社 · package insert May 8, 2024
Key facts
| Brand names | ホスホマイシンナトリウム静注用0.5g「日医工」, ホスホマイシンナトリウム静注用1g「日医工」, ホスホマイシンナトリウム静注用2g「日医工」 |
|---|---|
| Nonproprietary names | ホスホマイシンナトリウム |
| Companies | 製造販売元／日医工株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ホスホマイシン系抗生物質製剤 |
| Therapeutic category codes | 876135 |
| YJ codes | 6135400F1116, 6135400F2210, 6135400F3224 |
| Approval numbers | 22300AMX01202000, 22300AMX01203000, 22300AMX01204000 |
| Package insert edition | 第1版 |
| Package insert date | May 8, 2024 |
| PMDA document key | 530169_6135400F1116_1 |
| PMDA company code | 530169 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: